CONFERENCES

      World Congress for Bronchology & Interventional Pulmonology

      World Congress for Bronchology & Interventional Pulmonology (WCBIP) is an biennial event focusing on bronchology and interventional pulmonology, with topics ranging from lung cancer to emerging technologies. The event is open to scientists, academics, researchers, healthcare professionals, regulators, and industry experts, and provides a forum for sharing and collaborating to improve the diagnosis and treatment of pulmonary diseases. 

      World Congress for Bronchology & Interventional Pulmonology WCBIP 2020

      Date

      Nov 19, 2020 - Nov 22, 2020

      Location

      Online

      The theme of this Congress is “New Land, New Scope”. “New Land” implies that bronchology and interventional pulmonology is a new subfield of modern respiratory medicine, while “New Scope” means that new respiratory endoscopic techniques are being developed and that developing countries such as China are actively taking part in the field.  

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.